#' Simulated anti-inflammatory pain trial
#'
#' CTM_Nopain is a novel anti-inflammatory agent under preliminary investigation.
#' A dose-ranging trial was conducted comparing placebo with 3 doses of CTM_Nopain (5mg, 20mg and 80 mg QD).
#' The maximum tolerated dose is 160 mg per day.
#' Plasma concentrations (mg/L) of the drug were measured at 0, 0.5, 1, 1.5, 2, 2.5, 3-8 hours.
#' Pain score (0=no pain, 1=mild, 2=moderate, 3=severe) were obtained at time points when plasma concentration was collected.
#' A pain score of 2 or more is considered as no pain relief.
#' The model used is a one-compartment PK model with allometric model of weight on CL (exp 0.75) and volume (exp 1)
#' with direct PD effect (Emax model).
#'
#' \itemize{
#' \item ARM Factor with 4 levels
#' \item ID. Numerical ID (1-160)
#' \item TIME Time in hours
#' \item CONC Concentration (mg/L)
#' \item PAINRELIEF 0 (no relief) or 1 (relief)
#' \item PAINSCORE categorical pain score
#' \item DOSE Dose Given
#' }
#' @docType data
#' @keywords datasets
#' @name pain_relief
#' @usage data(pain_relief)
#' @format A data frame with 1920 rows and 7 variables
NULL
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.